Clinical Trial Update: Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tedizolid phosphate in adolescents with complicated skin and soft tissue infection has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Diseases Bacterial
• Skindiseases Infectious

Drugs mentioned

• Tedizolid Phosphate (tedizolid phosphate)

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Skin Diseases, Infectious, Skin Diseases, Bacterial | Phase 3 | Status: COMPLETED | Results posted: 2019-08-07